This strategy forms the basis for our approach between 2025 and 2030. Throughout this period, we will work with researchers, health professionals and policy makers, and across the commercial, ...

14 July 2025 to 25 July 2025 is PHG Foundation’s personalised health fortnight. Follow and share the campaign on LinkedIn Implementation of any new personalised health intervention requires more than ...

Unpacking the rhetoric of personalisation What does it take to personalise a health system? Two models have come to dominate responses to this challenge. One – commonly referred to as ‘ personalised ...

Hidden in plain sight: The untapped power of data for personalised health Dr Hayley Wilson identifies the impact that data can have in healthcare, whilst also looking at the current landscape of the ...

Metagenomic sequencing in public health – can long read sequencing be used to tackle antimicrobial resistance?

The Wellcome Trust recently announced that they are funding a research programme to investigate synthetic human genomes, and Laura Blackburn had the opportunity to comment for radio coverage of the ...

On Friday the High Court ruled on the case of ABC v St George’s NHS Trust (and other NHS defendants). This is a significant decision with implications for a wide range of healthcare professionals ...

Colin Mitchell sets out why our work to clarify the impact of the GDPR on the use of genomic data is so necessary. The work is funded by the Information Commissioner's Office ...

We are getting closer to a world where the debilitating pain and complications of sickle cell disease are a thing of the past. For the 17,500 people in the UK living with this genetic condition, this ...

In this blog, I will delve into some of the growing acceptance in healthcare to innovative approaches in various countries, and how a database will facilitate analysis and interpretation for all. The ...

The UK government has launched a new alliance to sequence the genomes of SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Backed by a £20 million investment, the COVID-19 Genomics ...

A new type of medicine that uses an approach called ‘gene silencing’ has been approved for use in the NHS in England.